Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KL130008 plus methotrexate in rheumatoid arthritis
CTR20202664Phase 2Completed
- Sponsor
- Kelun-Biotech
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KL130008 in rheumatoid arthritis (RA), sponsored by Kelun-Biotech. Started Dec 2020; status: completed.
02
Drugs
KL130008
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20202664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202664.